Interaction between nitric oxide and the cholinergic and sympathetic nervous system in cardiovascular control in humans

Pharmacology and Therapeutics

Volumn 106, Issue 2, 2005, Pages 209-220

  Sartori, Claudio ^a   Lepori, Mattia ^b   Scherrer, Urs ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Ospedale Regionale Bellinzona e Valli   (Switzerland)

Author keywords

Autonomic nervous system; Hypertension; Insulin resistance; Nitric oxide; Nitric oxide donors; Sympathectomy

Indexed keywords

ARGININE; ATROPINE; DYSTROPHIN; INSULIN; ISOPRENALINE; N(G) METHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PROPRANOLOL; SUPEROXIDE;

ADRENERGIC SYSTEM; ARTERIAL PRESSURE; BLOOD VESSEL TONE; CARDIOVASCULAR AUTOREGULATION; CHOLINERGIC RECEPTOR BLOCKING; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; DUCHENNE MUSCULAR DYSTROPHY; ESSENTIAL HYPERTENSION; EXERCISE; GENE MUTATION; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FAILURE; MENTAL STRESS; MOLECULAR MECHANICS; MUSCLE BLOOD FLOW; MUSCLE ISCHEMIA; MUSCLE PERFUSION; MUSCLE TONE; NITRERGIC NERVE; NONHUMAN; PATHOPHYSIOLOGY; PHYSICAL STRESS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SYMPATHECTOMY; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

EID: 18044365684     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2004.11.009     Document Type: Review

References (97)

1. F.M. Abboud, and J.W. Eckstein Active reflex vasodilatation in man Fed Proc 25 1966 1611 1617
2. V.C. Abrahams, and S.M. Hilton The role of active muscle vasodilatation in the alerting stage of the defense reaction J Physiol 171 1964 189 202
3. E.A. Anderson, R.P. Hoffman, T.W. Balon, C.A. Sinkey, and A.L. Mark Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans J Clin Invest 87 1991 2246 2252
4. E. Angaard Nitric oxide, mediator, murderer, and medicine Lancet 343 1994 1199 1206
5. H. Barcroft, and O.G. Edholm On the vasodilation in human skeletal muscle during post-haemorrhagic fainting J Physiol 104 1945 161 175
6. D.A. Blair, W.E. Glover, A.D. Greenfield, and I.C. Roddie Excitation of cholinergic vasodilator nerves to human skeletal muscles during emotional stress J Physiol 148 1959 633 647
7. R.H. Boger, and C. Zoccali ADMA; a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease Atherosclerosis 4 2003 23 28
8. E. Braunwald, H. Edmund, H. Sonneblick, and J.J. Ross Mechanisms of cardiac contraction and relaxation E. Braunwald Heart Disease 1992 W.B. Saunders Philadelphia 351 392
9. F. Brunner, P. Andrew, G. Wolkart, R. Zechner, and B. Mayer Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase Circulation 104 2001 3097 3102
10. J.K. Choate, E.J. Danson, J.F. Morris, and D.J. Paterson Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice Am J Physiol Heart Circ Physiol 281 2001 H2310 H2317
11. S. Chowdhary, J.C. Vaile, J. Fletcher, H.F. Ross, J.H. Coote, and J.N. Townend Nitric oxide and cardiac autonomic control in humans Hypertension 36 2000 264 269
12. S. Chowdhary, G.A. Ng, S.L. Nuttall, J.H. Coote, H.F. Ross, and J.N. Townend Nitric oxide and cardiac parasympathetic control in human heart failure Clin Sci (Lond) 102 2002 397 402
13. S. Chowdhary, A.M. Marsh, J.H. Coote, and J.N. Townend Nitric oxide and cardiac muscarinic control in humans Hypertension 43 2004 1023 1028
14. R.L. Converse Jr., T.N. Jacobsen, R.D. Toto, C.M. Jost, F. Cosentino, and F. Fouad-Tarazi Sympathetic overactivity in patients with chronic renal failure N Engl J Med 327 1992 1912 1918
15. S. Cook, and U. Scherrer Insulin resistance, a new target for nitric oxide-delivery drugs Fundam Clin Pharmacol 16 2002 441 453
16. S. Cook, O. Hugli, M. Egli, P. Vollenweider, R. Burcelin, and P. Nicod Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice Swiss Med Wkly 133 2003 360 363
17. S. Cook, O. Hugli, M. Egli, B. Ménard, S. Thalmann, and C. Sartori Partial gene deletion of endothelial NO synthase predisposes to exaggerated high-fat diet-induced insulin resistance and arterial hypertension Diabetes 53 2004 2067 2072
18. J. Cui, R. Zhang, T.E. Wilson, S. Witkowski, C.G. Crandall, and B.D. Levine Nitric oxide synthase inhibition does not affect regulation of muscle sympathetic nerve activity during head-up tilt Am J Physiol Heart Circ Physiol 285 2003 H2105 H2110
19. E.J. Danson, and D.J. Paterson Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise-trained mice J Physiol 546 2003 225 232
20. R.L. Davisson, A.K. Johnson, and S.J. Lewis Nitrosyl factors mediate active neurogenic hindquarter vasodilation in the conscious rat Hypertension 23 1994 962 966
21. N.M. Dietz, J.M. Rivera, S.E. Eggener, R.T. Fix, D.O. Warner, and M.J. Joyner Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans J Physiol 480 Pt 2 1994 361 368
22. H. Duplain, R. Burcelin, C. Sartori, S. Cook, M. Egli, and M. Lepori Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase Circulation 104 2001 342 345
23. F.C. Furlan, P.S. Marshall, R.F. Macedo, J.B. Carvalheira, J.B. Michelotto, and J.A. Gontijo Acute intracerebroventricular insulin microinjection after nitric oxide synthase inhibition of renal sodium handling in rats Life Sci 72 2003 2561 2569
24. M.A. Hakim, Y. Hirooka, M.J. Coleman, M.R. Bennett, and R.A. Dampney Evidence for a critical role of nitric oxide in the tonic excitation of rabbit renal sympathetic preganglionic neurones J Physiol 482 Pt 2 1995 401 407
25. J.R. Halliwill, L.A. Lawler, T.J. Eickhoff, N.M. Dietz, L.A. Nauss, and M.J. Joyner Forearm sympathetic withdrawal and vasodilatation during mental stress in humans J Physiol 504 Pt 1 1997 211 220
26. J. Hansen, T.N. Jacobsen, and R.G. Victor Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension 24 1994 439 444
27. S. Harada Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits Circ Res 72 1993 511 516
28. W. Haynes, J. Noon, B. Walker, and D. Webb Inhibition of nitric oxide synthesis increases blood pressure in healthy humans J Hypertens 11 1993 1375 1380
29. S. Henry, L. Trueb, C. Sartori, U. Scherrer, E. Jéquier, and L. Tappy Effects of a sympathetic activation by lower body negative pressure on glucose and lipid metabolism Clin Physiol 18 1998 562 569
30. N. Herring, E.J. Danson, and D.J. Paterson Cholinergic control of heart rate by nitric oxide is site specific News Physiol Sci 17 2002 202 206
31. T. Horn, P.M. Smith, B.E. McLaughlin, L. Bauce, G.S. Marks, and Q.J. Pittman Nitric oxide actions in paraventricular nucleus cardiovascular and neurochemical implications Am J Physiol 266 1994 R306 R313
32. M.J. Joyner, and N.M. Dietz Sympathetic vasodilation in human muscle Acta Physiol Scand 177 2003 329 336
33. M.J. Joyner, and J.R. Halliwill Sympathetic vasodilatation in human limbs J Physiol 526 Pt 3 2000 471 480
34. P. Jumrussirikul, J. Dinerman, T.M. Dawson, V.L. Dawson, U. Ekelund, and D. Georgakopoulos Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice J Clin Invest 102 1998 1279 1285
35. B.A. Kingwell Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease FASEB 14 2000 1685 1696
36. N. Kurihara, M.E. Alfie, D.H. Sigmon, N.E. Rhaleb, E.G. Shesely, and O.A. Carretero Role of nNOS in blood pressure regulation in eNOS null mutant mice Hypertension 32 1998 856 861
37. M. Laakso, S.V. Edelman, G. Brechtel, and A.D. Baron Decreased effect of insulin to stimulate muscle blood flow in obese man. A novel mechanism for insulin resistance J Clin Invest 85 1990 1844 1852
38. K.S. Lau, R.W. Grange, W.J. Chang, K.E. Kamm, I. Sarelius, and J.T. Stull Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide FEBS Lett 431 1998 71 74
39. G. Lembo, R. Napoli, B. Capaldo, V. Rendina, G. Iaccarino, and M. Volpe Abnormal sympathetic overactivity evoked by insulin in skeletal muscle of patients with essential hypertension J Clin Invest 90 1992 24 29
40. G. Lembo, G. Iaccarino, C. Vecchione, V. Rendina, L. Parella, and B. Trimarco Insulin modulation of b-adrenergic vasodilator pathway in human forearm Circulation 93 1996 1403 1410
41. M. Lepori, C. Sartori, L. Trueb, R. Owlya, P. Nicod, and U. Scherrer Hemodynamic and sympathetic effects of nitric-oxide synthase inhibition by systemic l-NMMA infusion in humans are dose dependent J Hypertens 16 1998 519 523
42. M. Lepori, C. Sartori, H. Duplain, P. Nicod, and U. Scherrer Sympathectomy potentiates the vasoconstrictor response to nitric oxide synthase inhibition in humans Cardiovasc Res 43 1999 739 743
43. M. Lepori, C. Sartori, H. Duplain, P. Nicod, and U. Scherrer Interaction between cholinergic and nitrergic vasodilation: a novel mechanism of blood pressure control Cardiovasc Res 51 2001 767 772
44. S. Lewis, H. Ohta, B. Machado, J. Bates, and W. Talman Microinjection of S-nitrosocysteine into the nucleus tractus solitarii decreases arterial pressure and heart rate via activation of soluble guanylate cyclase Eur J Pharmacol 202 1991 135 136
45. L. Linder, W. Kiowski, F.R. Bühler, and T.F. Lüscher Indirect evidence for the release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension Circulation 81 1990 1762 1767
46. T.E. Lindley, M.F. Doobay, R.V. Sharma, and R.L. Davisson Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure Circ Res 94 2004 402 409
47. K.E. Loke, C.G. Sobey, G.J. Dusting, and O.L. Woodman Cholinergic neurogenic vasodilation is mediated by nitric oxide in the dog hindlimb Cardiovasc Res 28 1994 542 547
48. F. Mallamaci, G. Tripepi, R. Maas, L. Malatino, R. Boger, and C. Zoccali Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease J Am Soc Nephrol 15 2004 435 441
49. A.L. Mark The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure J Hypertens Suppl 14 1996 S159 S165
50. C.M. Martin, A. Beltran-Del-Rio, A. Albrecht, R.R. Lorenz, and M.J. Joyner Local cholinergic mechanisms mediate nitric oxide-dependent flow-induced vasorelaxation in vitro Am J Physiol 270 1996 H442 H446
51. C.J. Mathias, D.F. Da Costa, P. Fosbraey, N.J. Christensen, and R. Bannister Hypotensive and sedative effects of insulin in autonomic failure Br Med J 295 1987 161 163
52. K. Matsukawa, T. Shindo, M. Shirai, and I. Ninomiya Nitric oxide mediates cat hindlimb cholinergic vasodilation induced by stimulation of posterior hypothalamus Jpn J Physiol 43 1993 473 483
53. P. Milner, K.A. Kirkpatrick, V. Ralevic, V. Toothill, J. Pearson, and G. Burnstock Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow Proc R Soc Lond B Biol Sci 241 1990 245 248
54. H. Miyano, T. Kawada, T. Shishido, T. Sato, M. Sugimachi, and J. Alexander Jr. Inhibition of NO synthesis minimally affects the dynamic baroreflex regulation of sympathetic nerve activity Am J Physiol 272 1997 H2446 H2452
55. S. Moncada, and A. Higgs The l-arginine-nitric oxide pathway N Engl J Med 329 1993 2002 2012
56. M.N. Muscara, and J.L. Wallace Nitric oxide.V. therapeutic potential of nitric oxide donors and inhibitors Am J Physiol 276 1999 G1313 G1316
57. T.D. Noakes The forgotten Barcroft/Edholm reflex: potential role in exercise associated collapse Br J Sports 37 2003 277 278
58. R. Owlya, L. Vollenweider, L. Trueb, C. Sartori, M. Lepori, and P. Nicod Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during exercise in humans Circulation 96 1997 3897 3903
59. R.M.J. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from l-arginine Nature 333 1988 664 666
60. J.A. Panza, P.R. Casino, C.M. Kilcoyne, and A.A. Quyyumi Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension Circulation 87 1993 1468 1474
61. J.F. Paton, S. Kasparov, and D.J. Paterson Nitric oxide and autonomic control of heart rate: a question of specificity Trends Neurosci 25 2002 626 631
62. M. Rand NANC transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission Clin Exp Pharmacol 19 1992 147 169
63. D. Randin, P. Vollenweider, L. Tappy, E. Jéquier, P. Nicod, and U. Scherrer Effects of adrenergic and cholinergic blockade on insulin- induced stimulation of calf blood flow in humans Am J Physiol 266 1994 R809 R816
64. A. Sakima, H. Teruya, M. Yamazato, R. Matayoshi, H. Muratani, and K. Fukiyama Prolonged NOS inhibition in the brain elevates blood pressure in normotensive rats Am J Physiol 275 1998 R410 R417
65. G-methyl-l-arginine, an inhibitor of l-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo Circ Res 70 1992 607 611
66. M. Sander, B. Chavoshan, S.A. Harris, S.T. Iannaccone, J.T. Stull, and G.D. Thomas Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy Proc Natl Acad Sci U S A 97 2000 13818 13823
67. J.S. Sanders, A.L. Mark, and D.W. Ferguson Evidence of cholinergically mediated vasodilation at the beginning of isometric exercise in humans Circulation 79 1989 815 824
68. C. Sartori, and U. Scherrer Insulin, nitric oxide and the sympathetic nervous system: at the crossroads of metabolic and cardiovascular regulation J Hypertens 17 1999 1517 1525
69. C. Sartori, L. Trueb, P. Nicod, and U. Scherrer Effects of sympathectomy and nitric oxide synthase inhibition on vascular actions of insulin in humans Hypertension 34 1999 586 589
70. U. Scherrer, and C. Sartori Insulin as a vascular and sympathoexcitatory hormone. Implications for blood pressure regulation, insulin sensitivity and cardiovascular morbidity Circulation 96 1997 4104 4113
71. U. Scherrer, and C. Sartori Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity Eur J Endocrinol 142 2000 315 323
72. U. Scherrer, P. Vollenweider, D. Randin, E. Jéquier, P. Nicod, and L. Tappy Suppression of insulin induced sympathetic activation and vasodilation by dexamethasone in humans Circulation 88 1993 388 394
73. U. Scherrer, D. Randin, L. Tappy, P. Vollenweider, E. Jéquier, and P. Nicod Body fat and sympathetic nerve activity in healthy subjects Circulation 89 1994 2634 2640
74. U. Scherrer, D. Randin, P. Vollenweider, L. Vollenweider, and P. Nicod Nitric oxide release accounts for insulin's vascular effects in humans J Clin Invest 94 1994 2511 2515
75. U. Scherrer, C. Sartori, M. Lepori, L. Trueb, and P. Nicod Nitric oxide and vascular reactivity in humans J Hypertens 16 1998 S37 S42
76. P. Schwarz, R. Diem, N.J. Dun, and U. Forstermann Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves Circ Res 77 1995 841 848
77. C.E. Sears, J.K. Choate, and D.J. Paterson Effect of nitric oxide synthase inhibition on the sympatho-vagal control of heart rate J Auton Nerv Syst 73 1998 63 73
78. C.E. Sears, E.A. Ashley, and B. Casadei Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? Philos Trans R Soc Lond B Biol Sci 359 2004 1021 1044
79. R. Shankar, J.S. Zhu, B. Ladd, D. Henry, H.Q. Shen, and A.D. Baron Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action J Clin Invest 102 1998 1403 1412
80. L. Sobrevia, A. Nadal, D.L. Yudilevich, and G.E. Mann Activation of l-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells J Physiol (Lond) 490 1996 775 781
81. H.O. Steinberg, G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release J Clin Invest 94 1994 1172 1179
82. S. Taddei, A. Virdis, P. Mattei, A. Natali, E. Ferrannini, and A. Salvetti Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension Circulation 92 1995 2911 2918
83. T. Tagawa, T. Imaizumi, S. Harada, T. Endo, M. Shiramoto, and Y. Hirooka Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brainstem slices Circ Res 75 1994 70 76
84. L. Tappy, K. Girardet, N. Schwaller, L. Vollenweider, E. Jéquier, and P. Nicod Metabolic effects of an increase of sympathetic activity in healthy humans Int J Obes 19 1995 419 422
85. G.D. Thomas, M. Sander, K.S. Lau, P.L. Huang, J.T. Stull, and R.G. Victor Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle Proc Natl Acad Sci U S A 95 1998 15090 15095
86. N. Toda, Y. Kitamura, and T. Okamura Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs Hypertension 21 1993 3 8
87. H. Togashi, I. Sakuma, M. Yoshioka, T. Kobayashi, H. Yasuda, and A. Kitabatake A central nervous system action of nitric oxide in blood pressure regulation J Pharmacol Exp Ther 262 1992 343 347
88. H. Togashi, M. Yoshioka, I. Sakuma, M. Matsumoto, H. Saito, and A. Kitabatake Central sympathectomy attenuates the hypertensive response to the acute and chronic administration of nitric oxide synthase inhibitors Circulation 90 1994 I-33
89. G. Vandecasteele, T. Eschenhagen, H. Scholz, B. Stein, I. Verde, and R. Fischmeister Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase Nat Med 5 1999 331 334
90. S. Verma, E. Arikawa, L. Yao, I. Laher, and J.H. McNeill Insulin-induced vasodilation is dependent on tetrahydrobiopterin synthesis Metabolism 47 1998 1037 1039
91. P. Vollenweider, L. Tappy, D. Randin, P. Schneiter, E. Jéquier, and P. Nicod Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans J Clin Invest 92 1993 147 154
92. P. Vollenweider, D. Randin, L. Tappy, E. Jéquier, P. Nicod, and U. Scherrer Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans J Clin Invest 93 1994 2365 2371
93. K. Yoshida, T. Okamura, H. Kimura, D. Bredt, S. Snyder, and N. Toda Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries Brain Res 629 1993 67 72
94. J. Zanzinger, J. Czachurski, and H. Seller Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo Circ Res 75 1994 1073 1077
95. A.M. Zeiher, H. Drexler, B. Saurbier, and H. Just Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension J Clin Invest 92 1993 652 662
96. G. Zeng, and M.J. Quon Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells J Clin Invest 98 1996 894 898
97. M.C. Zimmerman, E. Lazartigues, R.V. Sharma, and R.L. Davisson Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system Circ Res 95 2004 210 216